White			Black			Pair-wise comparisons of LS means p-value**
	Continent (Group 1)	SUI (Group 2)	UUI (Group 3)	Continent (Group 4)	SUI (Group 5)	UUI (Group 6)	Column A	Column B	Column C
	(n=46) LS Mean	(n=55) LS Mean	(n=44) LS Mean	(n=91) LS Mean	(n=47) LS Mean	(n=52) LS Mean	Differences by Status Among Whites 1v2 2v3 1v3	Differences by Status Among Blacks 4v5 5v6 4v6	Differences between B&W of same Status 1v4 2v5 3v6
URETHRAL FUNCTION CM H2O)
Maximal urethral closure pressure	55	45	45	66	51	68	1v2=0.007* 1v3=0.01	4v5=0.007 5v6=0.01	1v4=0.006 3v6<0.0001*
95% CI	50, 61	38, 50	38, 51	59, 71	40, 60	58, 77
Pressure increase with maximal contraction	19.0	18.4	10.4	21.3	18.6	19.0	1v3=0.0006* 2v3=0.002*		3v6=0.01
95% CI	15.2, 22.7	14.5, 22.2	6.4, 14.4	17.7, 25.0	12.1, 25.0	13.0, 25.1
URETHRAL AXIS “Q-TIP” DEGREES
Rest	−1	7	0	−3	1	−4	1v2=0.005* 2v3=0.01
95% CI	−4.1, 2.8	2.2, 9.3	−4.2, 3.2	−6.8, −0.1	−4.5, 7.3	−9.6, 1.4
Valsalva	25.4	28.5	20.9	20.2	24.4	19.0	2v3=0.04
95% CI	20.2, 30.6	23.1, 33.8	15.3, 26.6	15.1, 25.3	15.6, 33.3	10.7, 27.3
Pelvic Muscle Contraction	−17	−8	−7	−16	−9	−14	1v2<0.0001* 1v3<0.0001*	4v5=0.04	3v6=0.03
95% CI	−20.2, −13.3	−11.3, −4.2	−10.5, −3.1	−19.4, −12.5	−14.9, −3.0	−19.4, −8.0
UTERO-VAGINAL SUPPORT
Anterior Wall (Point Aa)	−0.9	−0.9	−1.4	−1.2	−0.3	−1.0		4v5=0.03
Apex (Point C)	−1.4, −0.5 −6.4	−1.4, −0.4 −6.5	−1.9, −0.9 −5.7	−1.6, −0.7 −6.5	−1.0, −0.5 −6.8	−1.7, −0.3 −6.6	1v3=0.04 2v3=0.01		3v6=0.047
Posterior Wall (Point B)	−6.9, −5.9 −1.1	−7.0, −6.0 −1.0	−6.2, −5.2 −1.4	−7.0, −6.0 −1.4	−7.7, −6.0 −1.1	−7.4, −5.8 −1.3	1v3=0.04 2v3=0.03
	−1.3, −0.8	−1.3, −0.8	−1.7, −1.2	−1.6, −1.1	−1.6, −0.7	−1.7, −0.8
HIATUS MEASUREMENTS
Genital Hiatus at rest	2.9 2.6, 3.1	3.2 2.9–3.4	3.0 2.8, 3.3	2.8 2.5, 3.0	3.2 2.8, 3.5	2.9 2.5, 3.2	1v2=0.04
Genital Hiatus with Valsalva	3.3 3.0, 3.5	3.8 3.5, 4.0	3.5 3.2, 3.7	3.2 2.9, 3.5	3.5 3.1, 3.9	3.6 3.1, 3.9	1v2=0.004*
VAGINAL CLOSURE FORCE N
Maximal contraction	3.2	3.1	1.9	3.0	3.1	2.9	1v3=0.0001* 2v3=0.002*		3v6=0.04
95% CI	2.7, 3.8	2.5, 3.6	1.3, 2.5	2.5, 3.6	2.2, 4.0	2.0, 3.7
Bladder Pressure Rest	22	22	25	24	25	24
	19.9, 24.0	19.9, 24.3	22.4, 26.9	22.3, 26.4	21.4, 28.6	20.6, 27.2
Maximal Cough	143	176	158	170	185	178	1v3=0.04 1v2<0.0001* 2v3=0.02		1v4=0.0001*
PVR	131, 154 49.2	164, 187 42.1	146, 170 32.8	159, 181 23.1	166, 204 26.1	160, 195 32.0	1v3=0.04		1v4=0.0005*
CMG 1st urge	37.3, 61.1 205.0	29.9, 54.3 215.3	20.1, 45.6 190.5	11.4, 34.8 217.0	5.9, 46.3 220.5	13.2, 50.8 208.7
CMG max	179, 231 396.9	189, 241 433.7	163, 218 389.4	192, 242 398.8	177, 264 395.0	168, 249 374.1	2v3=0.03
Max flow	367.8, 426.0 27.8	403.7, 463.8 32.8	358.3, 420.5 28.9	370.2, 427.3 30.0	345.2, 444.8 36.4	328.0, 420.2 28.3
Avg flow	23.8, 31.8 17.5	28.7, 36.9 18.8	24.5, 33.2 15.8	26.1, 34.0 19.2	29.5, 43.3 22.7	22.0, 34.6 18.5
	14.5, 20.6	15.7, 21.8	12.5, 19.0	16.2, 22.1	17.6, 27.8	13.8, 23.2

SUI, stress urinary incontinence; UUI, urge urinary incontinence; LS mean, least squares mean; CI, confidence interval.

Notation:

^*– remained statistically significant after Bonferroni correction.

^**only those with p < 0.05 shown

¹Data are weighted using clinic weights.

²Analyses are adjusted for age (continuous), body mass index (continuous), vaginal parity (0, 1–2, ≥3), and diabetes.

^*Excluded from this table are 7 women with ‘other’ incontinent symptoms, 29 women who demonstrated SUI on Valsalva only, and 22 women who reported symptoms of SUI but did not demonstrate SUI in the clinic.